Newomics Presents Platforms and Solutions at AACC 2019 (August 4-8, Anaheim)

Posted on 07.27.19

Newomics, which recently announced a co-marketing agreement with Thermo Fisher Scientific, announces that it will showcase its award-winning M3 emitters at the Innovation Zone in the Clinical Lab Expo Hall during the American Association for Clinical Chemistry (AACC) 2019 Annual Meeting (August 4-8, Anaheim, CA).

In addition, as part of the selection as a semi-finalist for the AACC 2019 Disruptive Technology Award Competition, Daojing Wang, Founder & CEO, will present a new platform for “Direct and Rapid Quantitation of Intact Proteins in Human Plasma by LC-MS (Without IP and Trypsin Digestion).” The presentation is scheduled for 2:00 pm on Tuesday, August 6th, 2019.